<p>(<b>A</b>) Off-rate values generated upon 3 vaccinations (marked with arrows) in a biweekly time period in BALB/c mice, followed by a single re-boost in week 54 (marked with an arrow), for samples (n = 10) taken at weeks 2, 4, 10, 30, 54 and 58. Values shown are means ±SEM. (<b>B</b>) R<sub>max</sub> values (n = 10) for the vaccination timecourse shown in (A). Values shown are means ±SEM. Note the re-boost effect seen at week 58 on the amount of antibodies (R<sub>max</sub> values) upon single re-vaccination in week 54. (<b>C</b>) Total cholesterol values for PCSK9-inoculated and control mice during a 58-week timecourse. Values are means ±SEM. Significance values were calculated by comparison with the control group, using a two-way ANOVA ...
<div><p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates expression of low-density li...
<p>(A) Groups of mice were primed and boosted with the same antigen, either Pfs48/45 or Pvs48/45. An...
<p>Blood samples were collected at day 21 and 33 post prime and on day 28 post challenge during acti...
<p>PCSK9 vaccine (V2 vaccine) was injected at a low dose (5 μg) or high dose (50 μg) peptide per mou...
<p>(<b>A</b>) Antibody titers (ODmax/2) against huPCSK9 protein, for sera generated from different p...
<p>(<b>A</b>) Long-term evaluation over 50 weeks post prime immunization of titers against huPCSK9 (...
<p>PCSK9 vaccine (V2 vaccine) or control (Saline) was injected at different doses (Low; 5 μg and Hig...
<p>(<b>A</b>) muPCSK9 levels in plasma samples from pre-immunized (W0) and post-immunized mice (W8)....
<p>Two candidate vaccines (V1 and V2 vaccines) or control (KLH) was injected (5 μg peptide per mouse...
<p>(<b>A</b>) Mean titers (ODmax/2) ±SEM against huPCSK9 (n = 9). (<b>B</b>) TC levels (mg/dL), bars...
half-lives necessitating frequent administration. Here, we evaluated the long-term efficacy and saf...
<p>Mice were vaccinated s.c. three times at three week intervals with lipid core peptides (LCP), or ...
<p>A) Prime-boost and challenge strategy. B) Lesion scores in mice primed with PR8-LACK<sub>ins</sub...
<p>ELISpot analysis for INF-γ-releasing splenocytes isolated from C57BL/6 (H-2D<sup>b</sup>) mice. (...
<p>(A,B) Single-dose vaccination. IFNAR<sup>-/-</sup> mice (n = 9 for Ad-N; n = 6 for Ad-wt) were va...
<div><p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates expression of low-density li...
<p>(A) Groups of mice were primed and boosted with the same antigen, either Pfs48/45 or Pvs48/45. An...
<p>Blood samples were collected at day 21 and 33 post prime and on day 28 post challenge during acti...
<p>PCSK9 vaccine (V2 vaccine) was injected at a low dose (5 μg) or high dose (50 μg) peptide per mou...
<p>(<b>A</b>) Antibody titers (ODmax/2) against huPCSK9 protein, for sera generated from different p...
<p>(<b>A</b>) Long-term evaluation over 50 weeks post prime immunization of titers against huPCSK9 (...
<p>PCSK9 vaccine (V2 vaccine) or control (Saline) was injected at different doses (Low; 5 μg and Hig...
<p>(<b>A</b>) muPCSK9 levels in plasma samples from pre-immunized (W0) and post-immunized mice (W8)....
<p>Two candidate vaccines (V1 and V2 vaccines) or control (KLH) was injected (5 μg peptide per mouse...
<p>(<b>A</b>) Mean titers (ODmax/2) ±SEM against huPCSK9 (n = 9). (<b>B</b>) TC levels (mg/dL), bars...
half-lives necessitating frequent administration. Here, we evaluated the long-term efficacy and saf...
<p>Mice were vaccinated s.c. three times at three week intervals with lipid core peptides (LCP), or ...
<p>A) Prime-boost and challenge strategy. B) Lesion scores in mice primed with PR8-LACK<sub>ins</sub...
<p>ELISpot analysis for INF-γ-releasing splenocytes isolated from C57BL/6 (H-2D<sup>b</sup>) mice. (...
<p>(A,B) Single-dose vaccination. IFNAR<sup>-/-</sup> mice (n = 9 for Ad-N; n = 6 for Ad-wt) were va...
<div><p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates expression of low-density li...
<p>(A) Groups of mice were primed and boosted with the same antigen, either Pfs48/45 or Pvs48/45. An...
<p>Blood samples were collected at day 21 and 33 post prime and on day 28 post challenge during acti...